SInclair is proud to announce ...

Recent exciting developments include the formation of Xenometrics™, an affiliate of Sinclair launched in September of 2006. Xenometrics™ is dedicated to providing state of the art safety pharmacology studies. Xenometrics consists of an experienced safety pharmacology team led by a leading expert in the field and will offer studies designed to satisfy global guidelines that have to be met prior to first administration in humans.

These studies comprise of:

1. Cardiovascular assessment in canines or primates by telemetry
2. In vitro electrophysiology studies
3. Respiratory assessment in rodents
4. CNS assessment in rodents
5. Drug metabolism and pharmacokinetics